Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revaccination with quadrivalent seasonal influenza vaccine in previously primed or unprimed young children
2012-001230-34Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Fluarix Quadrivalent in influenza (2 arms), sponsored by GSK. Primary endpoint: Serum hemagglutination inhibition antibody titres against each vaccine strain after 1 dose. Started Jul 2012; status: completed.
02
Drugs
Fluarix Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2012-001230-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001230-34.